Orphazyme A/S (ORPH) received a Notice of Allowance for its US patent application 16/879,198 titled "ARIMOCLOMOL FOR TREATING GLUCOCEREBROSIDASE ASSOCIATED DISORDERS" - PatentGrants

Go back to Orphazyme A/S (ORPH) received a Notice of Allowance for its US patent application 16/879,198 titled "ARIMOCLOMOL FOR TREATING GLUCOCEREBROSIDASE ASSOCIATED DISORDERS" - PatentGrants
(NASDAQ: ORPH) Delayed: 3.19 -0.05 (1.54%)
Previous Close $3.24    52 Week High
Open $3.18    52 Week Low
Day High $3.22    P/E N/A 
Day Low $3.14    EPS
Volume 144,364